Hi_老虎社区_美港股上老虎

GeraldHere
2021-09-09

White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>

The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according

White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":883399484,"tweetId":"883399484","gmtCreate":1631199792848,"gmtModify":1632883973921,"author":{"id":3557488303457204,"idStr":"3557488303457204","authorId":3557488303457204,"authorIdStr":"3557488303457204","name":"GeraldHere","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Hi</body></html>","htmlText":"<html><head></head><body>Hi</body></html>","text":"Hi","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/883399484","repostId":1176976417,"repostType":4,"repost":{"id":"1176976417","kind":"news","pubTimestamp":1631197026,"share":"https://www.laohu8.com/m/news/1176976417?lang=zh_CN&edition=full","pubTime":"2021-09-09 22:17","market":"us","language":"en","title":"White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1176976417","media":"Barron's","summary":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according","content":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>White House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhite House Will Announce Drug-Pricing Plan, WSJ Says. Pharma Stocks Are Down.<blockquote>《华尔街日报》称，白宫将宣布药品定价计划。医药股下跌。</blockquote>\n</h2>\n<h4 class=\"meta\">\n\nBarron's2021-09-09 22:17\n\n</h4>\n</header>\n<article>\nThe White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.<blockquote>根据周四早些时候发布的一份报告，白宫将于周四制定一项降低处方药价格的计划。华尔街日报.</blockquote> The plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.<blockquote>该计划将允许医疗保险就药品定价进行谈判，并允许卫生与公众服务部测试将药品支付与药品如何造福患者联系起来。杂志报告。</blockquote> The plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.<blockquote>该计划是在国会民主党人努力制定药品定价立法之际出台的。两党都支持降低处方药价格的努力，尽管特朗普政府在这个问题上进展甚微。</blockquote> The S&amp;P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&amp;P 500,&nbsp;which has risen 20.2%. The SPDR S&amp;P Biotech<blockquote>标普500制药指数今年迄今已上涨14.9%，落后于上涨20.2%的大盘标普500。SPDR标准普尔生物技术公司</blockquote> exchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.<blockquote>主要跟踪中小型生物技术行业的交易所交易基金（股票代码：XBI）同期下跌了6%。</blockquote> Shares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson &amp; Johnson&nbsp;(JNJ) shares declined 0.7%.<blockquote>周四凌晨，制药公司股价下跌。辉瑞(PFE)股价早盘下跌0.26%，礼来(LLY)股价下跌2.46%，默克(MRK)股价下跌1.17%，强生(JNJ)股价下跌0.7%。</blockquote> <img src=\"https://static.tigerbbs.com/1f3b476333002ca1b549be932aa2a442\" tg-width=\"275\" tg-height=\"163\" width=\"100%\" height=\"auto\"><blockquote></blockquote> Worries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.<blockquote>对限制药品价格努力的担忧长期以来一直困扰着生物技术和制药行业。一些分析师表示，对药品价格立法的新担忧可能是生物科技股近期疲软的驱动因素之一。</blockquote> According to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.<blockquote>根据杂志制药行业贸易组织PhRMA正在抵制据报道的白宫提案以及民主党在国会的努力，在周三的新闻看涨期权上表示，允许医疗保险就药品定价进行谈判将意味着用于资助新药开发的资金减少药物。</blockquote> “The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”<blockquote>据跟踪该行业的新闻媒体Fierce Pharma报道，默克董事长Kenneth Frazier在新闻看涨期权上表示：“我们从国会看到的提案将摧毁这个行业。”“虽然像默克这样的大公司将生存下来，但我们所做的研究将大大减少。”</blockquote> Lilly CEO David Ricks also spoke on the call.<blockquote>礼来公司首席执行官David Ricks也在看涨期权上发表了讲话。</blockquote> “From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.<blockquote>伯恩斯坦分析师罗尼·加尔在周二发布的一份报告中写道：“从制药行业的角度来看，价格谈判机制的建立将是一个重大的负面影响（因为其作用可能会随着时间的推移而扩大）。”</blockquote> In addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.<blockquote>除药品定价方案外，纽约时报报道称，拜登总统将于周四宣布一项计划，推动企业、学校和联邦政府采取严格的疫苗接种政策。</blockquote>\n<div class=\"bt-text\">\n\n\n 来源：<a href=\"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews\">Barron's</a>\n为提升您的阅读体验，我们对本页面进行了排版优化\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来","JNJ":"强生","PFE":"辉瑞"},"source_url":"https://www.marketwatch.com/articles/white-house-drug-pricing-pharma-stocks-51631195642?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176976417","content_text":"The White House is set to lay out a plan on Thursday to cut prices for prescription drugs, according to a report out early Thursday from The Wall Street Journal.\nThe plan will allow Medicare to negotiate on drug pricing, and would allow the Department of Health and Human Services to test linking payments for drugs to how the drugs benefit patients, according to the Journal report.\nThe plan would come amid an effort from Congressional Democrats to enact drug-pricing legislation. Both parties have supported efforts to cut prescription- drug prices, though the Trump administration made little progress on the issue.\nThe S&P 500 Pharmaceuticals index is up 14.9% so far this year, trailing behind the broader S&P 500, which has risen 20.2%. The SPDR S&P Biotech\nexchange- traded fund (ticker: XBI), which largely tracks the small and midcap biotech sector, has declined 6% over the same period.\nShares of pharma firms were down in the early morning on Thursday. Pfizer (PFE) shares were down 0.26% in early trading, while Eli Lilly(LLY) shares were down 2.46%, Merck (MRK) shares fell 1.17%, and Johnson & Johnson (JNJ) shares declined 0.7%.\n\nWorries over efforts to limit drug prices have been a long-term overhang on the biotech and pharmaceutical industries. Some analysts have suggested that renewed concerns over drug-price legislation could be one driver behind the recent weakness in biotech stocks.\nAccording to the Journal, the pharmaceutical industry trade group PhRMA is pushing back against the reported White House proposal, and the Democrats’ efforts in Congress, saying on a press call on Wednesday that allowing Medicare to negotiate for drug pricing would mean less money to fund the development of new drugs.\n“The proposals that we’re seeing from Congress will devastate this industry,” Merck chairman Kenneth Frazier said on the press call, according to a report from the news outlet Fierce Pharma, which tracks the industry. “While large companies like Merck will survive, we will do significantly less research.”\nLilly CEO David Ricks also spoke on the call.\n“From the drug industry perspective, the creation of a price negotiation mechanism would be a material negative (as its role may expand over time),” Bernstein analyst Ronny Gal wrote in a note out Tuesday.\nIn addition to the drug-pricing plan, the New York Times reported that President Biden will announce a plan on Thursday to push businesses, schools, and the federal government to adopt strict vaccination policies.","news_type":1,"symbols_score_info":{"LLY":0.9,"JNJ":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":939,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}